Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgM by ELISA (Inactive as of 08/19/24)
Also known as: HSV MC
Use
This test detects IgM antibodies to Herpes Simplex Virus types 1 and/or 2 using an ELISA methodology. However, it is not recommended for diagnostic use since IgM lacks adequate predictive value for acute HSV infection and may produce inaccurate or misleading results. If acute HSV infection is suspected, molecular testing (HSV‑1/HSV‑2 Subtype by PCR, test code 2010095) is preferred.([wellness.riverview.org](https://www.wellness.riverview.org/lab-test/herpes-simplex-virus-type-1-and-or-2-antibodies-igm-by-elisa/?utm_source=openai))
Special Instructions
The test has been discontinued (inactive as of August 19, 2024). Clinical recommendations suggest using molecular PCR testing for acute infection.([lab.parkview.com](https://lab.parkview.com/news-and-updates/news-archives/changes-in-herpes-simplex-virus-testing/?utm_source=openai))
Limitations
IgM tests for HSV are unreliable: they lack specificity between HSV‑1 and HSV‑2, may cross‑react with other viruses, and are prone to false positives and negatives, reducing their clinical utility. IgG testing or molecular testing is preferred.([wellness.riverview.org](https://www.wellness.riverview.org/lab-test/herpes-simplex-virus-type-1-and-or-2-antibodies-igm-by-elisa/?utm_source=openai))
Methodology
Immunoassay (ELISA)
Biomarkers
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
Not provided
Container
SST Gold tube
Other tests from different labs that may be relevant
